Tafasitamab-cxix (Monjuvi) 2025 Updates: Uses in Cancer, Dosage, Side Effects, Expectations, and More - OncoDaily Tafasitamab-cxix (Monjuvi) is used to treat relapsed or refractory B-cell lymphomas. Learn about its uses, side effects, dosage and expectations.

Tafasitamab-cxix (Monjuvi) 2025 Updates: Uses in Cancer, Dosage, Side Effects, Expectations, and More

oncodaily.com/drugs/tafasi...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Tafasitamab-cxix #Monjuvi #Lymphoma #IO

IncyteのMonjuvi®（タファシタマブ-cxix）がFDAに承認！再発・難治性の濾胞性リンパ腫に対し、リツキシマブ、レナリドミドとの併用療法として新たな選択肢。患者さんのQOL向上に期待！ 濾胞性リンパ腫 #Monjuvi #タファシタマブ #FDA承認 #Incyte #血液がん #新薬 Link